Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 305.00
Bid: 304.00
Ask: 306.00
Change: 1.50 (0.49%)
Spread: 2.00 (0.658%)
Open: 305.00
High: 305.00
Low: 305.00
Prev. Close: 303.50
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Mar 2017 16:31

RNS Number : 7386Z
Microgen PLC
16 March 2017
 

16 March 2017

 

MICROGEN plc (the "Company")

 

Director/PDMR Shareholding / Total Voting Rights

 

Microgen plc (LSE: MCGN), a leading provider of business critical software and services, provides notification that on 16 March 2017, following the exercise by a number of the Company's Executive Directors of options under the Microgen Plc Performance Share Plan 2006 ("PSP"), 780,618 new ordinary shares of 6 3/7 pence each in the Company ("Ordinary Shares") have been issued. The issued Ordinary Shares were admitted to the Official List of the UKLA and to trading on the main market of the London Stock Exchange on 25 November 2016.

 

Each of the Executive Directors named below exercised options over the number of Ordinary Shares specified below on 16 March 2017 with an exercise price per Ordinary Share of £0.05. The options had an expiry date of 18 November 2023.

 

Following the exercise of these options each Executive Director's overall shareholding in the Company has increased as set out in the following table. Each Executive Director also sold a number of the resulting Ordinary Shares on 16 March 2017 at a price of £2.70 per Ordinary Share, as set out below.

 

Name of Executive Director

No. of Options Exercised

No. of Ordinary Shares sold

No. of Ordinary Shares held prior to transactions

Number of Ordinary Shares held after transactions

 

Percentage of the issued share capital of the Company held prior to transactions

Percentage of the issued share capital of the Company held after transactions

Tom Crawford (CEO, Aptitude Software)

140,206

69,757

309,551

380,000

0.52%

0.63%

Simon Baines (CEO, Microgen Financial Systems)

320,206

229,729

9,523

100,000

0.02%

0.16%

Philip Wood (Chief Financial Officer)

320,206

230,841

110,635

200,000

0.18%

0.33%

 

In accordance with DTR 5.6.1, the Company also announces that, following the transactions referred to above, as at today's date, its issued share capital comprises 60,771,938 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. The voting rights of all of the Ordinary Shares are identical. Shareholders may use this figure as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Ordinary Shares in Microgen under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

The notification below, made pursuant to Article 19 of Regulation (EU) No 596/2014 on Market Abuse, provides further information about these transactions.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

(a)

Name

(i) Tom Crawford

(ii) Simon Baines

(iii) Philip Wood

 

2

Reason for the notification

 

(a)

Position/Status

(i) PDMR - (Chief Executive Officer, Aptitude Software)

(ii) PDMR - (Chief Executive Officer, Microgen Financial Systems)

(iii) PDMR - (Chief Financial Officer)

 

(b)

Initial notification / Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

Microgen Plc

 

(b)

LEI

2138009VHA1WI2VKMA28

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary Shares of 6 3/7 pence each

 

 

ISIN: GB00BVVHWX30

(b)

Nature of the transaction

 

(a) Exercise of options over Ordinary Shares

(b) Sale of Ordinary Shares

 

(c)

Price(s) and volume(s)

 

Name

(a) Exercise Price per Ordinary Share

(a) Number of Ordinary Shares over which Options Exercised

(b) Sale Price per Ordinary Share

(b) Number of Ordinary Shares sold

(i) Tom Crawford

£0.05

140,206

£2.70

69,757

(ii) Simon Baines

£0.05

320,206

£2.70

229,729

(iii) Philip Wood

£0.05

320,206

£2.70

230,841

(d)

Aggregated Information

- Aggregated Volume

- Price

n/a

(e)

Date of the Transaction

16 March 2017

 

(f)

Place of the Transaction

(a) Outside a trading venue

(b) London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, Microgen Plc

 

Contacts

Mark Heather, Company Secretary 020-7496-8100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUMPWUPMGQQ
Date   Source Headline
1st Nov 20214:50 pmRNSTotal Voting Rights
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company
4th May 20218:55 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAppointment of Joint Broker
27th Apr 202111:28 amRNSResult of AGM
27th Apr 20217:00 amRNSAGM Statement
9th Apr 202111:14 amRNSHolding(s) in Company
29th Mar 20212:06 pmRNSBlock listing Interim Review
23rd Mar 202111:13 amRNSDirector/PDMR Shareholding
11th Mar 20214:44 pmRNSBlock Listing Application
2nd Mar 20217:00 amRNSNotice of Results
1st Mar 202112:36 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSTrading Update
6th Jan 20214:23 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20209:13 amRNSHolding(s) in Company
1st Dec 202010:09 amRNSTotal Voting Rights
23rd Nov 20205:37 pmRNSHolding(s) in Company
28th Oct 20201:58 pmRNSDirector/PDMR Shareholding
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 202010:48 amRNSBlock listing Interim Review
9th Sep 20204:24 pmRNSGrant of awards under Performance Share Plan
2nd Sep 20201:38 pmRNSDirector Declaration
11th Aug 202012:19 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSInterim Results
6th Jul 20207:23 amRNSHolding(s) in Company
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.